Moderna vaccine 96 percent effective in 12-17 year-olds, study shows
Researchers find association between financial strain due to COVID-19 and depression
6 May 2021‘Natural disasters’ increase triggers for violence against women and girls
6 May 2021Moderna vaccine 96 percent effective in 12-17 year-olds, study shows
Moderna said Thursday its COVID-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.
